Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Modafinil

A wakefulness-promoting drug, developed in France in the 1970s and approved in 1994 in France and in 1998 in the United States, mainly for the excessive sleepiness of narcolepsy. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It is the main metabolite of adrafinil, an older compound from the same chemical series; French neurophysiologist Michel Jouvet, a leading sleep researcher, contributed to its development.

ModafinilGo to the active ingredient →
ModafinilActive ingredientModafinilCat. No. P-M155-001CAS 68693-11-8
Modafinil-d5Isotopically labelledModafinil-d5Cat. No. P-M155-016CAS 1133712-38-5
R-ModafinilImpurityR-ModafinilCat. No. P-M155-028CAS 112111-43-0

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Reference substanceModafinil CRSEDQM code Y0000635Family Modafinil

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.